Eisai buys Purdue stake in insomnia drug as PDUFA date nears

Eisai is buying Purdue Pharma’s stake in sleep disorder drug lemborexant. The deal gives Eisai sole responsibility for global development and commercialization of a drug that is nearing FDA approval.